Literature DB >> 34229059

NCAPD2 inhibits autophagy by regulating Ca2+/CAMKK2/AMPK/mTORC1 pathway and PARP-1/SIRT1 axis to promote colorectal cancer.

Zuolei Jing1, Xinyuan He2, Zhirong Jia2, Yunli Sa2, Bolin Yang3, Ping Liu4.   

Abstract

Non-SMC condensin I complex subunit D2 (NCAPD2) is one of the three non-SMC subunits in condensin I. Previous studies have shown that NCAPD2 plays an important role in the chromosome condensation and segregation. However, its role in the development of colorectal cancer (CRC) and specific molecular mechanisms still need to be further studied. Here we show that NCAPD2 inhibits autophagy and blocks autophagic flux via Ca2+/CAMKK/AMPK/mTORC1 pathway and PARP-1/SIRT1 axis. NCAPD2 acts as a tumor promoter both in vitro and in vivo. NCAPD2 knockout suppresses colorectal cancer development in AOM/DSS induced mice model. Therefore, our findings support a role for NCAPD2 in autophagy to promote CRC development and highlight NCAPD2 as a potential target for CRC therapy.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy; CAMKK/AMPK pathway; Colorectal cancer; NCAPD2; PARP-1/SIRT1

Mesh:

Substances:

Year:  2021        PMID: 34229059     DOI: 10.1016/j.canlet.2021.06.029

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway.

Authors:  Bo Li; Qian Xiao; Liping Shan; Yongsheng Song
Journal:  Cell Cycle       Date:  2022-01-02       Impact factor: 4.534

2.  NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer.

Authors:  Zuolei Jing; Qianmei Liu; Xinyuan He; Zhirong Jia; Zhizhong Xu; Bolin Yang; Ping Liu
Journal:  J Exp Clin Cancer Res       Date:  2022-06-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.